Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study

Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study

(2018) Dae Ho Lee et al.   BMC HEALTH SERVICES RESEARCH

Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study

(2017) J. de Castro et al.   EUROPEAN JOURNAL OF CANCER CARE

First-line treatment options for ALK -rearranged lung cancer

(2017) Benjamin Solomon   LANCET

Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer – final results from the prospective German TLK cohort study

(2017) Ulla von Verschuer et al.   LUNG CANCER

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

(2016) S. Novello et al.   ANNALS OF ONCOLOGY

The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics

(2016) Ting-Yuan David Cheng et al.   Journal of Thoracic Oncology

Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease

(2016) Crispin T Hiley et al.   LANCET

Real-World Evidence — What Is It and What Can It Tell Us?

(2016) Rachel E. Sherman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non–Small-Cell Lung Cancer

(2016) Adrian G. Sacher et al.   JAMA Oncology

Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer†

(2015) C. Lim et al.   ANNALS OF ONCOLOGY

The 2015 World Health Organization Classification of Lung Tumors

(2015) William D. Travis et al.   Journal of Thoracic Oncology

EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey

(2015) Yasushi Yatabe et al.   Journal of Thoracic Oncology

Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study

(2015) Denis Moro-Sibilot et al.   LUNG CANCER

Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

(2015) Amit Jain et al.   PLoS One

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study

(2014) Cesare Gridelli et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline

(2014) Natasha B. Leighl et al.   JOURNAL OF CLINICAL ONCOLOGY

Guideline Recommendations for Testing ofALKGene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group

(2014) Hyojin Kim et al.   Korean Journal of Pathology

ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non-Small Cell Lung Cancer

(2013) J. F. Gainor et al.   CLINICAL CANCER RESEARCH

Clinical management patterns and treatment outcomes in patients with non-small cell lung cancer (NSCLC) across Europe: EPICLIN-Lung study

(2013) A. Carrato et al.   CURRENT MEDICAL RESEARCH AND OPINION

Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007

(2013) Sarah Walters et al.   THORAX

Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study

(2012) Alain Vergnenegre et al.   CURRENT MEDICAL RESEARCH AND OPINION

Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: Baseline results of an observational study (FRAME)

(2012) Philipp A. Schnabel et al.   LUNG CANCER

A cross-country review of data collected on non-small cell lung cancer (NSCLC) patients in cancer registries, databases, retrospective and non-randomized prospective studies

(2012) Anna De Geer et al.   JOURNAL OF MEDICAL ECONOMICS

Personalized medicine for lung cancer: new challenges for pathology

(2011) Keith M Kerr   HISTOPATHOLOGY

Clinical and Testing Protocols for the Analysis of Epidermal Growth Factor Receptor Mutations in East Asian Patients with Non-small Cell Lung Cancer: A Combined Clinical-Molecular Pathological Approach

(2011) Manuel Salto-Tellez et al.   Journal of Thoracic Oncology

Tissue sampling in lung cancer: A review in light of the MERIT experience

(2011) Martin Reck et al.   LUNG CANCER

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group

(2011) Erik Thunnissen et al.   LUNG CANCER

The role of molecular analyses in the era of personalized therapy for advanced NSCLC

(2011) Nichole T. Tanner et al.   LUNG CANCER

Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study

(2010) Denis Moro-Sibilot et al.   CURRENT MEDICAL RESEARCH AND OPINION

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

(2009) Alice T. Shaw et al.   JOURNAL OF CLINICAL ONCOLOGY